alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Search

Search

322 results for "lecanemab".

Guides and answers on this site 41

Showing 1–10, page 1 of 5.

  1. Lecanemab and donanemab: benefit and riskPage

    Understand · alzhub.org/treatments/lecanemab

    Lecanemab and donanemab: do they work, and what are the risks? In the main trials both drugs slowed decline modestly over about 18 months in people with early Alzheimer's. Independent reviews disagree about whether that …

  2. Alzheimer's treatments: approved drugs, trials and failuresPage

    Main · alzhub.org/treatments

    … genuinely debated among specialists: lecanemab and donanemab, what the trials and the independent reviews found . The trial numbers, the FDA decisions and the ARIA rates for all three approved antibodies are side by side on the …

  3. Lecanemab (Leqembi): the researchPage

    Research · alzhub.org/answers/lecanemab

    Lecanemab (Leqembi): what the research library holds Lecanemab, sold as Leqembi, is an anti-amyloid antibody approved for early Alzheimer's disease. This page shows what the library holds on it. 287 studies in the library …

  4. What are lecanemab (Leqembi) and donanemab (Kisunla), and who can take them?Question

    Questions and answers · Treatment · alzhub.org/faq#anti-amyloid-drugs

    … infusion every four weeks; lecanemab is given intravenously or, in newer formulations, by subcutaneous injection. (Leqembi prescribing information) (Kisunla prescribing information) (FDA)

  5. Anti-amyloid antibodies for Alzheimer's: the trial evidencePage

    Understand · alzhub.org/treatments/anti-amyloid

    … 18-point CDR-SB scale with lecanemab over 18 months 0.70 points less worsening on the CDR-SB with donanemab over 76 weeks 107 extra cases of brain swelling (ARIA-E) per 1,000 people treated, across the class On this page What …

  6. Anti-amyloid drugs in 2026: where each one standsPage

    Articles · alzhub.org/blog/anti-amyloid-drugs-2026

    Anti-amyloid drugs in 2026: where lecanemab, donanemab and the rest stand Thirty years after the amyloid hypothesis, two antibodies that clear amyloid are approved in the US, one was approved and then abandoned, several failed …

  7. Getting Alzheimer's drugs covered: prior authorizationPage

    Support · alzhub.org/getting-covered

    … found and the risks, see lecanemab and donanemab: do they work? Compiled 2026-09-28. Every figure below carries the source it came from and whether that source is a government primary source or a named secondary one — see the …

  8. How to read an Alzheimer's research paperPage

    Articles · alzhub.org/blog/how-to-read-an-alzheimers-study

    … was excluded. Take the lecanemab trial in The New England Journal of Medicine . It enrolled 1,795 people aged 50 to 90 with early Alzheimer's, meaning mild cognitive impairment or mild dementia, and every one of them had amyloid …

  9. Contact usPage

    Main · alzhub.org/contact

    … clinical trials 3,152 Lecanemab (Leqembi) 287 All answer pages More in About This Site About This Site Contact All Pages

  10. Alzheimer's research by topic: 32 subjects, 30,580 studiesPage

    Research · alzhub.org/research/topics

    … the trials showed — lecanemab, donanemab and aducanumab, with every figure sourced to a library record or an FDA document. On this page Diagnosis, tests and early signs (7 subjects, 9,057 studies) Treatments and trials (4 …

How this search works

There is no outside search company involved. The site builds its own index by reading its own pages — the same words you would see on the page — and each result shows a literal snippet of that text with your words highlighted. Nothing is summarised or rewritten by a machine in between.

One addition, made by hand: a short list of everyday words that our pages cover under another name. Search "symptoms" and you are also shown The 10 warning signs; "medication" leads to Treatments & medicines; "hotline" to the helplines. A result reached that way shows the page's own description, and it only ever points to a page that already covers the subject.

30704 pages, questions, glossary terms and research summaries are indexed, last rebuilt 2026-11-11. Las páginas en español también aparecen en estos resultados. The clinical trial records are not in this index — they have their own finder, which searches all trial titles, sponsors and drugs directly.